Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Angiotensin-converting enzymes and drug discovery in cardiovascular diseases Shi L; Mao C; Xu Z; Zhang LDrug Discov Today 2010[May]; 15 (9-10): 332-41Angiotensin-converting enzyme (ACE) is a major target in the treatment of cardiovascular diseases (CVDs). In addition to ACE, ACE2 - which is a homolog of ACE and promotes the degradation of angiotensin II (Ang II) to Ang (1-7) - has been recognized recently as a potential therapeutic target in the management of CVDs. This article reviews different metabolic pathways of ACE and ACE2 (Ang I-Ang II-AT1 receptors and Ang I-Ang (1-7)-Mas receptors) in the regulation of cardiovascular function and their potential in new drug development in the therapy of CVDs. In addition, recent progress in the study of angiotensin and ACE in fetal origins of CVD, which might present an interesting field in perinatal medicine and preventive medicine, is briefly summarized.|Angiotensin-Converting Enzyme 2[MESH]|Angiotensin-Converting Enzyme Inhibitors/*administration & dosage/pharmacology[MESH]|Animals[MESH]|Brain/metabolism[MESH]|Cardiovascular Diseases/*drug therapy/*metabolism[MESH]|Cardiovascular System/metabolism[MESH]|Drug Delivery Systems/*methods[MESH]|Drug Discovery/*methods[MESH]|Fetus/metabolism[MESH]|Humans[MESH]|Models, Biological[MESH]|Peptidyl-Dipeptidase A/*metabolism[MESH]|Signal Transduction/drug effects[MESH] |